Indigenous and Traditional Uses of Psilocybin Mushrooms

Published 2026-07-30 · history · ethics · cultural-appropriation · mesoamerica · indigenous-rights · traditional-knowledge

For thousands of years, Indigenous peoples in Mesoamerica have used psilocybin-containing mushrooms in sacred ceremonies. These traditions long predate Western scientific interest in psychedelics and remain living practices — not historical relics. As psilocybin re-enters global conversation through clinical research and drug-policy reform, understanding these Indigenous traditions, and the ethical questions surrounding their appropriation, has become increasingly important.

Historical and Archaeological Evidence

Evidence of ceremonial mushroom use in Mesoamerica stretches back millennia. Stone carvings resembling mushrooms, sometimes bearing human or animal figures, have been found in Guatemala, southern Mexico, and other parts of Central America. Some archaeologists date these artefacts to as early as 1000 BCE, though interpretations remain debated and the field has moved cautiously away from sweeping claims about their meaning.

Spanish colonial records from the 16th century provide more direct accounts. Fray Bernardino de Sahagún, a Franciscan friar who documented Aztec life in the Florentine Codex, described mushrooms known in Nahuatl as teonanácatl — commonly translated as "flesh of the gods" or "divine mushroom." He and other chroniclers noted their use in religious and healing ceremonies. The Spanish colonial authorities, regarding these practices as pagan, sought to suppress them — driving mushroom use into secrecy in remote communities, where it survived for centuries.

The Mazatec Tradition

Among the best-documented living traditions is that of the Mazatec people of the Sierra Mazateca in Oaxaca, Mexico. In Mazatec ceremonial practice, psilocybin mushrooms are understood as sacred beings — not as drugs or medicines in the Western sense. Ceremonies known as veladas are conducted by curanderos and curanderas (healers), who ingest mushrooms as part of healing, divination, and communal ritual. These ceremonies typically take place at night, in darkness, with prayer, song, and quiet intention.

The mushrooms are treated with deep reverence. Their handling follows customary protocols passed through oral tradition across generations. The healer's role is central — not merely as a supplier but as an experienced guide who works with the mushrooms on behalf of the individual and the community. María Sabina (c. 1894–1985), a Mazatec curandera from Huautla de Jiménez, became perhaps the most widely recognised figure associated with these traditions. Her veladas drew on a sophisticated cosmology expressed through song, prayer, and what she described as direct communion with the mushrooms.

The Western Encounter and Its Consequences

In 1955, the American amateur mycologist R. Gordon Wasson travelled to Huautla de Jiménez and attended a velada led by María Sabina. His account, published in LIFE magazine in 1957 under the title "Seeking the Magic Mushroom," introduced these traditions — and the mushrooms themselves — to a Western mass audience. Many credit Wasson's article with catalysing modern Western interest in psychedelics, though the story is more complex than a single article. Wasson built on the earlier work of Mexican anthropologist Roberto Weitlaner, and other researchers were already aware of mushroom ceremonies in the region.

What is clear is that the article brought a flood of foreign visitors to Huautla de Jiménez. Some came as serious researchers; many more came as tourists. María Sabina reportedly expressed regret about the exposure, suggesting that outsiders had weakened the power of the mushrooms by treating them as curiosities rather than sacred beings. The influx disrupted community life, attracted the attention of Mexican law enforcement, and contributed to a growing commercialisation that bore little resemblance to Mazatec practice.

Cultural Appropriation and Ethical Questions

The commercialisation of Indigenous psilocybin traditions raises difficult ethical questions. In countries including Mexico, Costa Rica, and the Netherlands, businesses offer "shamanic retreats" with psilocybin ceremonies to paying clients — often with little or no connection to the Indigenous communities whose knowledge they draw upon. Ceremonial forms are sometimes replicated in superficial ways, stripped of the language, cosmology, and community context that give them meaning.

Scholars and Indigenous advocates have raised concerns about bioprospecting — the extraction of traditional knowledge for commercial or pharmaceutical benefit without fair compensation or recognition. Psilocybin, as a compound, is now the subject of patent applications and clinical trials. Yet the communities that preserved and developed this knowledge over centuries rarely share in any financial benefits.

International frameworks offer relevant principles. The UN Declaration on the Rights of Indigenous Peoples (2007) affirms Indigenous peoples' right to maintain, control, and develop their cultural traditions and knowledge. The Nagoya Protocol under the Convention on Biological Diversity addresses access to genetic resources and the fair and equitable sharing of benefits arising from their use. Neither instrument was designed specifically for psychedelics, but both provide frameworks for thinking about who holds knowledge, who benefits from it, and who decides. These questions also intersect with drug policy: if psilocybin is eventually rescheduled for therapeutic use, on what terms, and with whose input?

The South African Lens

South Africa, where psilocybin remains a Schedule 7 substance under the Medicines and Related Substances Act, faces its own questions about traditional medicine and Indigenous knowledge. While psilocybin mushrooms are not prominently documented in Southern African Indigenous practice in the way they are in Mesoamerica, the broader conversation about recognising and protecting traditional knowledge is deeply relevant. The country's constitutional protections for cultural and communal life, and its ongoing debates about the regulation of traditional health practitioners, provide a domestic framework for engaging with these international discussions.

As South Africa considers its own approach to psychedelic policy reform — and as it reflects on the cannabis precedent, where the Constitutional Court centred privacy rights — the experience of Mesoamerican communities offers a cautionary lesson. Knowledge taken without respect, context, or reciprocity can cause lasting harm, even when the stated intention is healing.

Sources and further reading

Back the campaign

Free The Fungi campaigns for evidence-based psilocybin policy reform in South Africa. If this was useful, add your name to the petition or join the community discussion.

This article was generated automatically from a curated topic brief and published without individual editorial review.This article is general reference information — not medical, legal, or professional advice, and not instructions for producing or using any controlled substance. Always verify against official sources.